The pars tuberalis (PT) is a distinct subdivision of the anterior pituitary gland that plays a central role in regulating seasonal prolactin release. In sheep, there is compelling evidence that seasonal changes in light, transformed into a melatonin signal, are interpreted by the PT to modulate the release of a factor which affects prolactin release. The identity of this factor(s) is unknown but has been preemptively called ‘tuberalin’. In the present study, we report on an initial immunocytochemical investigation where we have identified that many ovine PT cells are immunoreactive for the tachykinin substance P (SP). Few cells in the pars distalis immunoreact for SP. The SP-immunoreactive cells did not colocalize with β-luteinizing hormone. RT-PCR confirmed the presence of preprotachykinin A mRNA in the PT. We hypothesize that SP, and possibly other preprotachykinin A-derived tachykinins, may play a role in the seasonal regulation of prolactin secretion in sheep.

1.
Ueyama T, Krout KE, Van Nguyen X, Karpitskiy V, Kollert A, Mettenleiter TC, Loewy AD: Suprachiasmatic nucleus: a central autonomic clock. Nature Neurosci 1999;2:1051–1053.
2.
Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W: Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958;80:2587–2590.
3.
Arendt J: Melatonin and the Mammalian Pineal Gland. Cambridge, Chapman and Hall, 1995.
4.
Williams LM, Morgan PJ: Demonstration of melatonin-binding sites on the pars tuberalis of the rat. J Endocrinol 1988;119:R1–R3.
5.
Stanton TL, Siucia JA, Dubocovich ML, Krause DN: The area of 2-[125I]iodomelatonin binding in the pars tuberalis of the ground squirrel is decreased during hibernation. Brain Res 1991;557:285–288.
6.
Weaver DR, Reppert SM: Melatonin receptors are present in the ferret pars tuberalis and pars distalis, but not in brain. Endocrinology 1990;127:2607–2609.
7.
Morgan PJ, Williams LM, Davidson G, Lawson W, Howell E: Melatonin receptors in the ovine pars tuberalis: characterization and autoradiographical localization. J Neuroendocrinol 1989;1:1–4.
8.
Malpaux B, Skinner DC, Maurice F: The ovine pars tuberalis does not appear to be targeted by melatonin to modulate luteinizing hormone secretion, but may be important for prolactin release. J Neuroendocrinol 1995;7:199–206.
9.
Malpaux B, Daveau A, Maurice-Mandon F, Duarte G, Chemineau P: Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology 1998;139:1508–1516.
10.
Craven AJ, Ormandy CJ, Robertson FG, Wilkins RJ, Kelly PA, Nixon AJ, Pearson AJ: Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology 2001;142:2533–2539.
11.
Curlewis JD, Sibbald AM, Milne JA, McNeilly AS: Chronic treatment with long-acting bromocriptine does not affect duration of the breeding season, voluntary food intake, body weight, or wool growth in the Scottish blackface ewe. Reprod Fertil Dev 1991;3:25–33.
12.
Lincoln G, Clarke IJ, Hut R, Hazlerigg DG: Characterizing a mammalian circannual pacemaker. Science 2006;314:1941–1944.
13.
Lincoln GA, Clarke IJ: Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 1994;6:251–260.
14.
Maywood ES, Hastings MH: Lesions of the iodomelatonin-binding sites of the mediobasal hypothalamus spare the lactotropic, but block the gonadotropic response of the male Syrian hamsters to short photoperiod and to melatonin. Endocrinology 1995;136:144–153.
15.
Bergmann M, Wittkowski W, Hoffmann K: Ultrastructural localisation of thyrotropin (TSH)-like immunoreactivity in specific secretory cells of the hypophyseal pars tuberalis in the Djungarian hamster, Phodopus sungorus. Cell Tissue Res 1989;256:649–652.
16.
Böckers TM, Sourgens H, Wittkowski W, Jekat A, Pera F: Changes in TSH-immunoreactivity in the pars tuberalis and pars distalis of the fetal rat hypophysis following maternal administration of propylthiouracil and thyroxine. Cell Tissue Res 1990;260:403–408.
17.
Wittkowski W, Bergmann M, Hoffmann K, Pera F: Photoperiod-dependent changes in TSH-like immunoreactivity of cells in the hypophysial pars tuberalis of the Djungarian hamster, Phodopus sungorus. Cell Tissue Res 1988;251:183–187.
18.
Nakao N, Ono H, Yamamura T, Anraku T, Takagi T, Higashi K, Yasuo S, Katou Y, Kageyama S, Uno Y, Kasukawa T, Iigo M, Sharp PJ, Iwasawa A, Suzuki Y, Sugano S, Niimi T, Mizutani M, Namikawa T, Ebihara S, Ueda HR, Yoshimura T: Thyrotrophin in the pars tuberalis triggers photoperiodic response. Nature 2008;452:317–322.
19.
Skinner DC, Robinson JE: The pars tuberalis of the ewe: no effect of season or ovariectomy on the distribution, density or presence of immunoreactive cells. Cell Tissue Res 1996;284:117–123.
20.
Böckers TM, Bockmann J, Fauteck JD, Kreutz MR, Bock R, Wittkowski W: Pars tuberalis-specific cells in the ovine pituitary do express common alpha-chain of glycoprotein hormones: an in situ hybridization and immunocytochemical study. Eur J Endocrinol 1994;131:540–546.
21.
Gross DS, Turgeon JL, Waring DW: The ovine pars tuberalis: a naturally occurring source of partially purified gonadotropes which secrete luteinizing hormone in vitro. Endocrinology 1984;114:2084–2091.
22.
Morgan PJ: The pars tuberalis: the missing link in the photoperiodic regulation of prolactin secretion? J Neuroendocrinol 2000;12:287–295.
23.
Wittkowski W, Bockmann J, Kreutz MR, Böckers TM: Cell and molecular biology of the pars tuberalis of the pituitary. Int Rev Cytol 1999;185:157–194.
24.
Morgan PJ, Webster CA, Mercer JG, Ross AW, Hazlerigg DG, MacLean A, Barrett P: The ovine pars tuberalis secretes a factor(s) that regulates gene expression in both lactotropic and nonlactotropic pituitary cells. Endocrinology 1996;137:4018–4026.
25.
Guerra M, Rodriguez EM: Identification, cellular and subcellular distribution of 21 and 72 kDa proteins (tuberalins?) secreted by specific cells of the pars tuberalis. J Endocrinol 2001;168:363–379.
26.
Johnston JD: Photoperiodic regulation of prolactin secretion: changes in intra-pituitary signalling and lactotroph heterogeneity. J Endocrinol 2004;180:351–356.
27.
Lincoln G: Melatonin modulation of prolactin and gonadotrophin secretion. Systems ancient and modern. Adv Exp Med Biol 1999;460:137–153.
28.
Graham ES, Webster CA, Hazlerigg DG, Morgan PJ: Evidence for the biosynthesis of a prolactin-releasing factor from the ovine pars tuberalis, which is distinct from thyrotropin-releasing hormone. J Neuroendocrinol 2002;14:945–954.
29.
Morgan PJ, Barrett P, Davidson G, Lawson W: Melatonin regulates the synthesis and secretion of several proteins by pars tuberalis cells of the ovine pituitary. J Neuroendocrinol 1992;4:557–563.
30.
Morgan PJ, Mercer JG: Control of seasonality by melatonin. Proc Nutr Soc 1994;53:483–493.
31.
Debeljuk L, Lasaga M: Tachykinins and the control of prolactin secretion. Peptides 2006;27:3007–3019.
32.
Albertson AJ, Talbott H, Wang Q, Jensen D, Skinner DC: The gonadotropin releasing hormone type I receptor is expressed in the mouse cerebellum. Cerebellum 2008, Epub ahead of print.
33.
Reibiger I, Aust G, Tscheudschilsuren G, Beyer R, Gebhardt C, Spanel-Borowski K: The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage. Neurosci Lett 2001;299:49–52.
34.
Lutz L, Dufourny L, Skinner DC: Effect of nutrient restriction on the somatotropes and substance P-immunoreactive cells in the pituitary of the female ovine fetus. Growth Horm IGF Res 2006;16:108–118.
35.
Skinner DC, Robinson JE: Melatonin-binding sites in the gonadotroph-enriched zona tuberalis of ewes. J Reprod Fertil 1995;104:243–250.
36.
Szkudlarek U, Cannon D, Corbally N, Traczyk WZ: Substance P in the blood plasma in hypophysial portal vessels. Acta Physiol Pol 1986;37:92–99.
37.
Clarke IJ, Jessop D, Millar R, Morris M, Bloom S, Lightman S, Coen CW, Lew R, Smith I: Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep. Neuroendocrinology 1993;57:765–775.
38.
Satake H, Kawada T: Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr Drug Targets 2006;7:963–974.
39.
Larsen PJ, Saermark T, Mau SE: Binding of an iodinated substance P analogue to cultured anterior pituitary prolactin- and luteinizing hormone-containing cells. J Histochem Cytochem 1992;40:487–493.
40.
Thomas GB, Cummins JT, Griffin N, Clarke IJ: Effect and site of action of hypothalamic neuropeptides on prolactin release in sheep. Neuroendocrinology 1988;48:252–257.
41.
Villablanca AC, Hanley MR: 17β-Estradiol stimulates substance P receptor gene expression. Mol Cell Endocrinol 1997;135:109–117.
42.
Pisera D, Theas S, De Laurentiis A, Lasaga M, Duvilanski B, Seilicovich A: The hormonal status modulates the effect of neurokinin A on prolactin secretion in female rats. J Endocrinol 1998;159:389–395.
43.
Abe H, Kato Y, Chihara K, Iwasaki Y, Imura H: Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release. Proc Soc Exp Biol Med 1980;165:248–252.
44.
Rivier C, Brown M, Vale W: Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat. Endocrinology 1977;100:751–754.
45.
Gullner HG, Yajima H, Herbert D, Owen WW: Growth hormone, prolactin and FSH release by the tachykinin dodecapeptide kassinin in the rat. Arch Int Pharmacodyn 1982;256:4–9.
46.
Vijayan E, McCann S: Effects of substance P and neurotensin on growth hormone and thyrotropin release in vivo and in vitro. Life Sci 1980;26:321–327.
47.
Henriksen JS, Saermark T, Vilhardt H, Mau SE: Tachykinins induce secretion of prolactin from perifused rat anterior pituitary cells by interactions with two different binding sites. J Recept Signal Transduct Res 1995;15:529–541.
48.
Mau SE, Witt MR, Saermark T, Vilhardt H: Substance P increases intracellular Ca2+ in individual rat pituitary lactotrophs, somatotrophs, and gonadotrophs. Mol Cell Endocrinol 1997;126:193–201.
49.
Duvilanski BH, Pisera D, Seilicovich A, del Carmen Diaz M, Lasaga M, Isovich E, Velardez MO: Interaction between substance P and TRH in the control of prolactin release. J Endocrinol 2000;166:373–380.
50.
Coiro V, Volpi R, Capretti L, Caiazza A, Caffarri G, Rossi G, Marchesi C, Chiodera P: Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. Horm Res 1993;39:73–76.
51.
Williams LM, Kelly D, Hannah LT, Morgan PJ: Localization of [125I]IGF-1 binding on the ovine pars tuberalis. J Neuroendocrinol 1995;7:931–938.
52.
Iqbal J, Pompolo S, Considine RV, Clarke IJ: Localization of leptin receptor-like immunoreactivity in the corticotropes, somatotropes, and gonadotropes in the ovine anterior pituitary. Endocrinology 2000;141:1515–1520.
53.
Hanon EA, Lincoln GA, Fustin JM, Dardente H, Masson-Pevet M, Morgan PJ, Hazlerigg DG: Ancestral TSH mechanism signals summer in a photoperiodic mammal. Curr Biol 2008;18:1147–1152.
54.
Takeda Y, Krause JE: Neuropeptide K potently stimulates the salivary gland secretion and potentiates substance P-induced salivation. Proc Natl Acad Sci USA 1989;86:392–396.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.